MobileSmith, Inc. MOST OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score

12/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

MobileSmith, Inc. (MOST) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 11/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

12/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

✗

护城河

35/100

→ Income

✗

成长

15/100

→ Income

✗

收入

10/100

→ Income

估值概览 — MOST

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率36.28

EV/EBITDA0.0

每股数据

EPS (TTM)$-0.71

每股账面价值$0.00

每股营收$0.06

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2012	$-0.24	$480.12K	$-4.4M	-916.2%
2013	$-1.50	$339.04K	$-27.53M	-8119.8%
2014	$-0.37	$879.09K	$-7.34M	-834.8%
2015	$-0.39	$1.82M	$-7.72M	-423.8%
2016	$-0.38	$1.87M	$-7.5M	-402.1%
2017	$-0.25	$3.45M	$-6.08M	-176.1%
2018	$-0.29	$2.32M	$-8.33M	-358.8%
2019	$-0.39	$2.8M	$-11.01M	-392.8%
2020	$-2.52	$2.2M	$-71.41M	-3250.2%
2021	$-0.71	$1.57M	$-20.15M	-1281%